Cargando…
Infusion with Human Bone Marrow-derived Mesenchymal Stem Cells Improves β-cell Function in Patients and Non-obese Mice with Severe Diabetes
Mesenchymal stem cells (MSCs) transplantation is a promising therapeutic strategy for type 1 diabetes (T1D). However, little is known on whether MSC transplantation can benefit T1D patients with ketoacidosis and its potential actions. Here, we show that infusion with bone marrow MSCs preserves β-cel...
Autores principales: | Li, Lirong, Hui, Hui, Jia, Xiaolei, Zhang, Jie, Liu, Ying, Xu, Qianyue, Zhu, Dalong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5131346/ https://www.ncbi.nlm.nih.gov/pubmed/27905403 http://dx.doi.org/10.1038/srep37894 |
Ejemplares similares
-
Infusion of Bone Marrow Mesenchymal Stem Cells Attenuates Experimental Severe Acute Pancreatitis in Rats
por: Zhao, Hang, et al.
Publicado: (2016) -
Bone marrow-derived mesenchymal stem cells migrate to healthy and damaged salivary glands following stem cell infusion
por: Schwarz, Silke, et al.
Publicado: (2014) -
β-Cell Regeneration Mediated by Human Bone Marrow Mesenchymal Stem Cells
por: Milanesi, Anna, et al.
Publicado: (2012) -
Bone Marrow Mesenchymal Stem-Cell-Derived Exosomes Ameliorate Deoxynivalenol-Induced Mice Liver Damage
por: Meng, Zitong, et al.
Publicado: (2023) -
Identification of Myocardial Telocytes and Bone Marrow Mesenchymal Stem Cells in Mice
por: Zhong, Xin, et al.
Publicado: (2018)